NTES-S
09999
BILIBILI-W
09626
ALI HEALTH
00241
TRIP.COM-S
09961
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -284.31%-306.36M | ---- | -122.38%-79.72M | ---- | 199.17%356.25M | ---- | -71.07%-359.24M | -29.61%73.59M | -53.05%-210M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 29.69%-103.44M | ---- | -43.50%-147.11M | ---- | 3.98%-102.51M | ---- | 39.39%-106.77M | ---- | 7.70%-176.14M |
Interest expense - adjustment | ---- | 89.41%87.14M | ---- | 136.12%46.01M | ---- | -38.29%19.48M | ---- | -9.21%31.58M | ---- | 38.20%34.78M |
Dividend (income)- adjustment | ---- | -65.70%-11.31M | ---- | 92.64%-6.83M | ---- | -4,798.05%-92.82M | ---- | 38.81%-1.9M | ---- | -1,158.94%-3.1M |
Investment loss (gain) | ---- | -30.58%-161.55M | ---- | ---123.72M | ---- | ---- | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | -20.57%193.18M | ---- | -13.55%243.22M | ---- | 24.93%281.35M |
Impairment and provisions: | ---- | 38.51%28.78M | ---- | 248.89%20.78M | ---- | -189.27%-13.96M | ---- | 34.72%15.63M | ---- | 1,538.98%11.6M |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---13.88M | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | 38.51%28.78M | ---- | 25,753.09%20.78M | ---- | -100.52%-81K | ---- | 34.72%15.63M | ---- | 1,538.98%11.6M |
Revaluation surplus: | ---- | 67.51%541.18M | ---- | 377.81%323.06M | ---- | -74.85%67.61M | ---- | 59.78%268.83M | ---- | 119.49%168.25M |
-Fair value of investment properties (increase) | ---- | 2,109.58%253.48M | ---- | 575.42%11.47M | ---- | -109.33%-2.41M | ---- | 669.24%25.87M | ---- | 94.44%-4.55M |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---30.2M |
-Other fair value changes | ---- | -7.67%287.7M | ---- | 344.96%311.59M | ---- | -71.18%70.03M | ---- | 19.69%242.96M | ---- | 28.10%203M |
Asset sale loss (gain): | ---- | -174.42%-419K | ---- | --563K | ---- | ---- | ---- | 93.02%-6K | ---- | 95.90%-86K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,831.07%-1.99M | ---- | 95.09%-103K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -174.42%-419K | ---- | --563K | ---- | ---- | ---- | 11,564.71%1.98M | ---- | --17K |
Depreciation and amortization: | ---- | -9.62%23.45M | ---- | -20.38%25.95M | ---- | -3.52%32.59M | ---- | -39.67%33.78M | ---- | 5.52%55.99M |
Special items | ---- | ---- | ---- | 100.00%5K | ---- | ---309.16M | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | 65.24%97.47M | ---- | -60.85%58.99M | ---- | 20.40%150.67M | ---- | -23.06%125.14M | -29.61%73.59M | 214.80%162.65M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -318.02%-7.77M | ---- | -116.38%-1.86M | ---- | 188.71%11.35M | ---- | 30.62%-12.79M | ---- | 13.25%-18.44M |
Accounts receivable (increase)decrease | ---- | 471.29%19.43M | ---- | -149.45%-5.23M | ---- | -11.16%10.58M | ---- | -92.68%11.91M | -103.28%-3.78M | 350.91%162.79M |
Accounts payable increase (decrease) | ---- | -796.42%-22.34M | ---- | 111.85%3.21M | ---- | -198.98%-27.06M | ---- | 71.27%-9.05M | ---- | -519.34%-31.51M |
Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | ---- | -80.93%28.36M | ---- | -26.19%148.76M | -80.17%36.4M | 181.74%201.54M |
Special items for working capital changes | ---- | 703.85%43.18M | ---- | 95.15%-7.15M | ---- | -451.95%-147.31M | ---- | 162.24%41.86M | -109.88%-29.08M | -110.83%-67.25M |
Cash from business operations | 654.61%82.84M | 171.00%129.96M | 113.49%10.98M | 80.33%47.96M | -233.63%-81.39M | -91.30%26.59M | -21.02%60.91M | -25.37%305.82M | -88.95%77.13M | 22.47%409.78M |
Other taxs | -38.51%-26.33M | 46.67%-37.34M | 67.73%-19.01M | -63.04%-70.01M | -160.00%-58.92M | 0.98%-42.94M | 7.22%-22.66M | 24.18%-43.36M | 21.00%-24.43M | -12.09%-57.19M |
Interest received - operating | -41.37%4.86M | 575.78%72.21M | -25.48%8.29M | -53.53%10.69M | 303.88%11.13M | 3.53%22.99M | -74.98%2.76M | -25.77%22.21M | 38.65%11.01M | -67.75%29.92M |
Net cash from operations | 23,778.99%61.37M | 1,549.96%164.83M | 100.20%257K | -271.02%-11.37M | -415.08%-129.19M | -97.66%6.65M | -35.64%41M | -25.58%284.66M | -90.56%63.71M | 1.63%382.51M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -64.64%5.94M | -60.78%21.88M | -77.15%16.79M | -63.55%55.79M | 369.64%73.49M | 261.04%153.05M | -21.16%15.65M | -64.92%42.39M | -46.77%19.85M | 43.22%120.83M |
Dividend received - investment | 37.93%9.48M | 65.70%11.31M | 35.80%6.87M | -85.37%6.83M | -27.69%5.06M | 2,363.43%46.68M | 992.04%7M | -38.81%1.9M | -61.25%641K | 1,158.94%3.1M |
Loan receivable (increase) decrease | 19.41%-6.32M | -8.75%-15.69M | -334.79%-7.84M | 34.13%-14.43M | 105.49%3.34M | 91.85%-21.9M | 56.45%-60.87M | -199.04%-268.68M | ---139.75M | 659.89%271.29M |
Decrease in deposits (increase) | 142.88%66.56M | 64.59%-305.77M | 79.77%-155.23M | -2,335.11%-863.52M | -7,044.84%-767.41M | 76.60%-35.46M | 104.13%11.05M | -248.68%-151.51M | -73.28%-267.73M | 118.07%101.91M |
Sale of fixed assets | 82.66%769K | -25.84%419K | 5,914.29%421K | 374.79%565K | --7K | -94.27%119K | ---- | 2,434.15%2.08M | ---- | --82K |
Purchase of fixed assets | 6.46%-2.11M | 14.42%-3.38M | 15.95%-2.26M | -50.30%-3.95M | -10.11%-2.69M | 69.93%-2.63M | 26.31%-2.44M | 51.20%-8.75M | -18.40%-3.31M | -80.78%-17.92M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -78.06%813K | ---- | 150.16%3.71M |
Recovery of cash from investments | --4.97M | -99.14%8.28M | ---- | -29.63%967.49M | 40.65%607.86M | -5.18%1.37B | -53.15%432.17M | 105.14%1.45B | 637.90%922.37M | -53.84%706.82M |
Cash on investment | ---- | 41.55%-516.18M | 80.15%-13.5M | 61.99%-883.11M | 95.54%-67.99M | -59.88%-2.32B | -66.05%-1.52B | -14.07%-1.45B | -366.47%-917.81M | 33.74%-1.27B |
Other items in the investment business | 2,076.12%34.27M | ---- | -107.17%-1.73M | 588.33%47.75M | 75.19%-837K | 89.61%-9.78M | 96.84%-3.37M | -132,626.76%-94.09M | -3,432.65%-106.9M | 100.15%71K |
Net cash from investment operations | 172.56%113.54M | -16.39%-799.13M | -4.90%-156.48M | 16.07%-686.59M | 86.74%-149.17M | -70.83%-818.07M | -128.33%-1.12B | -470.56%-478.89M | -160.05%-492.65M | 90.67%-83.93M |
Net cash before financing | 211.97%174.91M | 9.12%-634.3M | 43.88%-156.22M | 13.98%-697.95M | 74.32%-278.36M | -317.78%-811.42M | -152.68%-1.08B | -165.05%-194.22M | -188.38%-428.94M | 157.07%298.58M |
Cash flow from financing activities | ||||||||||
New borrowing | --1.32B | 90.74%515M | ---- | -71.73%270M | --100M | 1,301.63%955M | ---- | -39.17%68.14M | ---- | -88.92%112M |
Refund | -7,509.52%-1.2B | -44.12%-102.9M | ---15.75M | 89.58%-71.4M | ---- | -508.40%-685M | ---- | 66.90%-112.59M | 99.72%-586K | 54.21%-340.11M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --793.21M | --793.21M | ---- | ---- | ---- |
Interest paid - financing | -129.63%-57.84M | -136.28%-83.32M | -112.50%-25.19M | -98.41%-35.27M | -19.20%-11.85M | 40.64%-17.77M | 42.06%-9.95M | 8.98%-29.94M | -5.52%-17.16M | -30.71%-32.89M |
Dividends paid - financing | ---39.6M | 69.35%-17.76M | ---- | ---57.94M | ---- | ---- | ---- | ---- | ---- | -188.75%-68.18M |
Net cash from financing operations | 162.31%26.08M | 205.39%309.18M | -148.90%-41.85M | -90.22%101.24M | -89.01%85.59M | 1,339.49%1.04B | 3,603.98%778.44M | 75.32%-83.56M | 90.30%-22.22M | -254.54%-338.53M |
Effect of rate | 82.46%-3.51M | 91.32%-8.38M | 64.08%-20.03M | -344.59%-96.53M | ---55.76M | -55.88%39.47M | ---- | 357.01%89.47M | -1,526.97%-26.6M | 59.42%-34.81M |
Net Cash | 201.47%200.99M | 45.51%-325.13M | -2.75%-198.07M | -366.09%-596.71M | 36.88%-192.77M | 180.73%224.25M | 32.30%-305.41M | -595.30%-277.78M | -276.03%-451.15M | 86.86%-39.95M |
Begining period cash | -39.42%512.6M | -45.03%846.11M | -45.03%846.11M | 20.67%1.54B | 20.67%1.54B | -12.86%1.28B | -12.86%1.28B | -4.86%1.46B | -4.86%1.46B | -20.22%1.54B |
Items Period | ---- | ---- | ---- | ---- | ---- | ---- | --12.13M | ---- | ---- | ---- |
Cash at the end | 13.07%710.07M | -39.42%512.6M | -51.35%628.01M | -45.03%846.11M | 31.40%1.29B | 20.67%1.54B | -0.39%982.36M | -12.86%1.28B | -45.01%986.2M | -4.86%1.46B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.